These effects are mediated through the activation of transient receptor potential melastatin 7 (TRPM7) channel and the blockade of TRPM7 channels abolishes the leptin-induced hypertension (Shin et al., 2019a, 2021). The gene discussed is TRPM7; the disease is hypertensive disorder.